Pieris Pharmaceuticals Inc (NAS:PIRS)
$ 10.2 0.05 (0.49%) Market Cap: 13.47 Mil Enterprise Value: -12.97 Mil PE Ratio: 0 PB Ratio: 0.57 GF Score: 46/100

Q4 2021 Pieris Pharmaceuticals Inc Earnings Call Transcript

Mar 01, 2022 / 01:00PM GMT
Release Date Price: $245.6 (-0.65%)
Operator

Greetings, and welcome to the Pieris Pharmaceuticals Year-End Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded.

I would now like to turn the call over to Tom Bures, Chief Financial Officer. Thank you. You may begin.

Thomas Bures
Pieris Pharmaceuticals, Inc. - Senior VP & CFO

Thank you. Good morning, everyone, and thank you for joining us for our year-end 2021 conference call and corporate update. On the call today, we have Steve Yoder, our President and CEO, who will provide a corporate overview and outlook on our pipeline; Tim Demuth, our Chief Medical Officer; Hitto Kaufmann, our Chief Scientific Officer; and Shane Olwill, our Chief Development Officer, who will be available for Q&A. You can access the press release released this morning on the Investor Relations page of our website at www.pieris.com.

Before we begin, I'd like to caution that comments made during this conference call may contain forward-looking statements involving

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot